Anthropic IPO: What Does the S-1 Mean for Life Sciences?
Anthropic’s IPO reveals its growing influence in life sciences, from pharmaceutical AI adoption and automated laboratories to AI-assisted drug discovery.
Real-Time Clinical Trials Are a Huge Competitive Advantage
Real-time clinical trials enable continuous data capture and faster decisions, improving how data is used in clinical trials. Here is what pharma leaders need to know.
Operation TrialBlazer: Can the U.S. Reclaim Clinical Trial Leadership?
Operation TrialBlazer aims to reignite U.S. clinical development by accelerating trials, modernising FDA oversight, and strengthening pharmaceutical innovation.
The Latest Evidence on Informed Consent in Clinical Trials
A recent systematic review reveals incredible detail about informed consent in clinical trials, participant understanding, and trial quality. Find out now.
Characteristics of Successful Single Pivotal Trials
Single pivotal trials can support regulatory approval when evidence is strong. Explore trial design, efficacy data, statistics, and regulatory strategy.
Claude Science: An Operating System for AI-Driven Pharma R&D
Claude Science is a new AI R&D tool for drug discovery, integrating 60-plus scientific databases into one place. Here is what pharma R&D teams need to know.